Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized double-blind placebo-controlled study of KHK4577 in atopic dermatitis
jRCT2080222314Phase 2
- Sponsor
- Kyowa Kirin
- Start
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in atopic dermatitis (AD) comparing KHK4577 with Placebo (2 arms).
02
Drugs
KHK4577
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on jRCT2080222314.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222314.